66 related articles for article (PubMed ID: 20194890)
1. CYLD regulates angiogenesis by mediating vascular endothelial cell migration.
Gao J; Sun L; Huo L; Liu M; Li D; Zhou J
Blood; 2010 May; 115(20):4130-7. PubMed ID: 20194890
[TBL] [Abstract][Full Text] [Related]
2. Regulation of lymphatic-blood vessel separation by endothelial Rac1.
D'Amico G; Jones DT; Nye E; Sapienza K; Ramjuan AR; Reynolds LE; Robinson SD; Kostourou V; Martinez D; Aubyn D; Grose R; Thomas GJ; Spencer-Dene B; Zicha D; Davies D; Tybulewicz V; Hodivala-Dilke KM
Development; 2009 Dec; 136(23):4043-53. PubMed ID: 19906871
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of endothelial cell migration.
Michaelis UR
Cell Mol Life Sci; 2014 Nov; 71(21):4131-48. PubMed ID: 25038776
[TBL] [Abstract][Full Text] [Related]
4. CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma.
Li Y; Yang C; Xie L; Shi F; Tang M; Luo X; Liu N; Hu X; Zhu Y; Bode AM; Gao Q; Zhou J; Fan J; Li X; Cao Y
Cell Death Dis; 2024 Jan; 15(1):95. PubMed ID: 38287022
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
[TBL] [Abstract][Full Text] [Related]
6. CYLD-mediated signaling and diseases.
Mathis BJ; Lai Y; Qu C; Janicki JS; Cui T
Curr Drug Targets; 2015; 16(4):284-94. PubMed ID: 25342597
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasis.
Xue Y; Xue C; Song W
Cell Oncol (Dordr); 2024 Feb; ():. PubMed ID: 38324230
[TBL] [Abstract][Full Text] [Related]
8. The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation.
Huang Z; Tan Y
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176077
[TBL] [Abstract][Full Text] [Related]
9. Mouse endothelial OTUD1 promotes angiotensin II-induced vascular remodeling by deubiquitinating SMAD3.
Huang Z; Shen S; Wang M; Li W; Wu G; Huang W; Luo W; Liang G
EMBO Rep; 2023 Mar; 24(3):e56135. PubMed ID: 36579465
[TBL] [Abstract][Full Text] [Related]
10. Understanding the underlying mechanisms governing spindle orientation: How far are we from there?
Zhong T; Gongye X; Wang M; Yu J
J Cell Mol Med; 2022 Oct; 26(19):4904-4910. PubMed ID: 36029193
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-96: A therapeutic and diagnostic tumor marker.
Rahimi HR; Mojarrad M; Moghbeli M
Iran J Basic Med Sci; 2022 Jan; 25(1):3-13. PubMed ID: 35656454
[TBL] [Abstract][Full Text] [Related]
12. Potential role for the tumor suppressor CYLD in brain and notochord development.
Li T; Wang Y; Li D; Zhou J; Zhang B; He X
Thorac Cancer; 2021 Jun; 12(12):1900-1908. PubMed ID: 33982884
[TBL] [Abstract][Full Text] [Related]
13. CYLD deficiency causes auditory neuropathy due to reduced neurite outgrowth.
Yang S; Ma N; Wu X; Ni H; Gao S; Sun L; Zhou P; Tala ; Ran J; Zhou J; Liu M; Li D
J Clin Lab Anal; 2021 Jun; 35(6):e23783. PubMed ID: 33934395
[TBL] [Abstract][Full Text] [Related]
14. Functions of Endothelial Cilia in the Regulation of Vascular Barriers.
Ma N; Zhou J
Front Cell Dev Biol; 2020; 8():626. PubMed ID: 32733899
[TBL] [Abstract][Full Text] [Related]
15. The Role of Deubiquitinases in Vascular Diseases.
Wang B; Cai W; Ai D; Zhang X; Yao L
J Cardiovasc Transl Res; 2020 Apr; 13(2):131-141. PubMed ID: 31823221
[TBL] [Abstract][Full Text] [Related]
16. Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model.
de Jel MM; Schott M; Lamm S; Neuhuber W; Kuphal S; Bosserhoff AK
Oncogenesis; 2019 Oct; 8(10):56. PubMed ID: 31591386
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase 6 modulates macrophage infiltration during inflammation.
Yan B; Xie S; Liu Y; Liu W; Li D; Liu M; Luo HR; Zhou J
Theranostics; 2018; 8(11):2927-2938. PubMed ID: 29896294
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of protocadherin γ subfamily A12 and solute carrier family 19 A 1 promoters contributes to the occurrence and metastasis of colorectal cancer.
Zhang C; Li J; Huang T; Chen C; Hong Q; Ji H; Ye M; Duan S
Oncol Lett; 2018 Jun; 15(6):8215-8222. PubMed ID: 29805555
[TBL] [Abstract][Full Text] [Related]
19. EB1 phosphorylation mediates the functions of ASK1 in pancreatic cancer development.
Gao S; Luo Y; Wu X; Li Y; Zhou Y; Lyu R; Liu M; Li D; Zhou J
Oncotarget; 2017 Nov; 8(58):98233-98241. PubMed ID: 29228685
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic Acid A Inhibits OX-LDL Effects on Exacerbating Choroidal Neovascularization via Downregulating CYLD.
Mao K; Shu W; Liu L; Gu Q; Qiu Q; Wu X
Oxid Med Cell Longev; 2017; 2017():6210694. PubMed ID: 29081889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
